Nanjing Immunophage Biotech Co., Ltd

This early-stage study tested a new oral drug called IPG1094 in 76 healthy adults aged 18-50. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects. This is a fi…

This early-stage study tested a new oral drug, IPG11406, in 66 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo. The goal was not to treat any disease, but to gather important safety and dosing information for f…